Mark Bodenrader

Mark Bodenrader has a strong background in finance and accounting, with over 25 years of experience in various roles. Currently, they serve as the Senior Vice President, Finance and Chief Accounting Officer at Cerevel Therapeutics, LLC, where they are responsible for all aspects of financial management and strategy. Prior to this, Mark held roles at Biogen, where they served as Corporate Controller and was responsible for worldwide close-to-report processes and SEC reporting. Mark also worked at Heritage Property Investment Trust as the Head of Internal Audit, at Grant Thornton LLP as a Manager in Assurance and Business Advisory Services, at Cabot Industrial Trust as an Assistant Controller, and at Arthur Andersen LLP in Assurance and Business Advisory Services. Throughout their career, Mark has demonstrated expertise in financial reporting, accounting policies, and capital formation.

Mark Bodenrader earned a Bachelor of Science (BS) degree with a dual major in Finance and Accounting from Merrimack College. Mark completed their education at Merrimack College from 1990 to 1994. Additionally, Mark has obtained a certification as a Certified Public Accountant (CPA), although specific details regarding the institution and year of completion were not provided.